Adial Pharmaceuticals Inc [NASDAQ: ADIL] gained 23.58% on the last trading session, reaching $1.31 price per share at the time.
If compared to the average trading volume of 159.61K shares, ADIL reached a trading volume of 159710691 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Here is what top equities market gurus are saying about Adial Pharmaceuticals Inc [ADIL]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ADIL shares is $7.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ADIL stock is a recommendation set at 1.67. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Maxim Group have made an estimate for Adial Pharmaceuticals Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 30, 2018. While these analysts kept the previous recommendation, Dawson James raised their target price to Buy. The new note on the price target was released on October 11, 2018, representing the official price target for Adial Pharmaceuticals Inc stock.
The Average True Range (ATR) for Adial Pharmaceuticals Inc is set at 0.21 The Price to Book ratio for the last quarter was 0.87, with the Price to Cash per share for the same quarter was set at 1.19.
Trading performance analysis for ADIL stock
Adial Pharmaceuticals Inc [ADIL] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 16.96. With this latest performance, ADIL shares gained by 16.96% in over the last four-week period, additionally plugging by 0.15% over the last 6 months – not to mention a drop of -80.30% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ADIL stock in for the last two-week period is set at 61.65, with the RSI for the last a single of trading hit 71.36, and the three-weeks RSI is set at 54.99 for Adial Pharmaceuticals Inc [ADIL]. The present Moving Average for the last 50 days of trading for this stock 1.2397, while it was recorded at 1.1180 for the last single week of trading, and 1.6715 for the last 200 days.
Adial Pharmaceuticals Inc [ADIL]: A deeper dive into fundamental analysis
Adial Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 9.48 and a Current Ratio set at 9.48.
An analysis of Institutional ownership at Adial Pharmaceuticals Inc [ADIL]
The top three institutional holders of ADIL stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in ADIL stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in ADIL stock with ownership which is approximately 5.1238%.
